Global Biotech Partnering Terms and Agreements 2017-2021

Publisher Name :
Date: 01-Mar-2021
No. of pages: 2900
Inquire Before Buying

Global Biotech Partnering Terms and Agreements 2017 to 2021 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Biotech agreements announced in the life sciences since 2017.

The report takes the reader through a comprehensive review Biotech deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Biotech partnering deals.

The report presents financial deal term values for Biotech deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Biotech partnering field; both the leading deal values and most active Biotech dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 4,900 online deal records of actual Biotech deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Biotech dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Biotech dealmaking since 2017, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Biotech deals since 2017. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Biotech dealmaking with a brief summary followed by a comprehensive listing of Biotech deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Biotech partnering deals signed and announced since Jan 2017, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Biotech partnering deals signed and announced since Jan 2017. The chapter is organized by specific technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Biotech partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Biotech partnering and dealmaking since 2017.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Biotech technologies and products.

Key benefits

Global Biotech Partnering Terms and Agreements 2017 to 2021 provides the reader with the following key benefits:

In-depth understanding of Biotech deal trends since 2017

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Biotech agreements with real life case studies

Detailed access to actual Biotech contracts entered into by leading biopharma companies

Identify most active Biotech dealmakers since 2017

Insight into terms included in a Biotech partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Biotech Partnering Terms and Agreements 2017 to 2021 is intended to provide the reader with an in-depth understanding and access to Biotech trends and structure of deals entered into by leading companies worldwide.

Biotech Partnering Terms and Agreements includes:

Trends in Biotech dealmaking in the biopharma industry since 2017

Analysis of Biotech deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Biotech deals

Access to Biotech contract documents

Leading Biotech deals by value since 2017

Most active Biotech dealmakers since 2017

In Global Biotech Partnering Terms and Agreements 2017 to 2021, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Biotech Partnering Terms and Agreements 2017 to 2021 report provides comprehensive access to available deals and contract documents for over 4,900 Biotech deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Biotech Partnering Terms and Agreements 2017-2021 provides the reader with the following key benefits:

In-depth understanding of Biotech deal trends since 2017

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Biotech agreements with real life case studies

Detailed access to actual Biotech contracts entered into by leading biopharma companies

Identify most active Biotech dealmakers since 2017

Insight into terms included in a Biotech partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Global Biotech Partnering Terms and Agreements 2017-2021

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Biotech dealmaking
2.1. Introduction
2.2. Biotech partnering over the years
2.3. Most active Biotech dealmakers
2.4. Biotech partnering by deal type
2.5. Biotech partnering by therapy area
2.6. Biotech partnering by technology type
2.7. Deal terms for Biotech partnering
2.7.1 Biotech partnering headline values
2.7.2 Biotech deal upfront payments
2.7.3 Biotech deal milestone payments
2.7.4 Biotech royalty rates

Chapter 3 - Leading Biotech deals
3.1. Introduction
3.2. Top Biotech deals by value

Chapter 4 - Most active Biotech dealmakers
4.1. Introduction
4.2. Most active Biotech dealmakers
4.3. Most active Biotech partnering company profiles

Chapter 5 - Biotech contracts dealmaking directory
5.1. Introduction
5.2. Biotech contracts dealmaking directory

Chapter 6 - Biotech dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking
Appendices
Appendix 1 - Biotech deals by company A-Z
Appendix 2 - Biotech deals by stage of development
Appendix 3 - Biotech deals by deal type
Appendix 4 - Biotech deals by therapy area
Appendix 5 - Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Tables of Figures

Figure 1: Biotech partnering since 2017
Figure 2: Active Biotech dealmaking activity- 2017 to 2021
Figure 3: Biotech partnering by deal type since 2017
Figure 4: Biotech partnering by disease type since 2017
Figure 5: Biotech partnering by technology type since 2017
Figure 6: Biotech deals with a headline value
Figure 7: Biotech deals with an upfront value
Figure 8: Biotech deals with a milestone value
Figure 9: Biotech deals with a royalty rate value
Figure 10: Top Biotech deals by value since 2017
Figure 11: Most active Biotech dealmakers 2017 to 2021
  • Global Separation Systems for Commercial Biotechnology Sales Market Report 2021
    Published: 13-Apr-2021        Price: US 4000 Onwards        Pages: 128
    The global Separation Systems for Commercial Biotechnology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Separation Systems for Commercial Biotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Ty......
  • Global Antibody Fragments Sales Market Report 2021
    Published: 13-Apr-2021        Price: US 4000 Onwards        Pages: 131
    The global Antibody Fragments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Fragments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - F(ab) Fragment - F(ab')2 Fragment......
  • Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025
    Published: 13-Apr-2021        Price: US 4950 Onwards        Pages: 189
    “The oxidative stress assay market is projected to grow at a CAGR of 9.7% during the forecast period.” The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market inc......
  • Global Molecular Biology Kits Sales Market Report 2021
    Published: 12-Apr-2021        Price: US 4000 Onwards        Pages: 133
    The global Molecular Biology Kits market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Biology Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - DNA Isolation Kits - RNA Isolat......
  • Global Antibody Services Market Size, Status and Forecast 2021-2027
    Published: 12-Apr-2021        Price: US 3900 Onwards        Pages: 123
    Global Antibody Services Scope and Market Size Antibody Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - ......
  • (Post-pandemic Era) - Global White Biotechnology Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 93
    Summary This study analysis was given on a worldwide scale, for instance, present and historical White Biotechnology growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in relat......
  • (Post-pandemic Era) - Global White Biotechnology Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 114
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global White Biotechnology Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Label-free Array Systems Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 86
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Label-free Array Systems growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs